Document Type
Article
Publication Date
11-6-2024
Identifier
DOI: 10.1186/s12866-024-03598-6
Abstract
BACKGROUND: Pathogenic Escherichia coli strains produce neonatal septicemia after colonizing the neonatal gut. While the probiotic Lactobacillus rhamnosus GG (LGG) effectively reduces neonatal sepsis, LGG's effects on the neonatal intestinal microbiota alterations and inflammation triggered by E. coli are incompletely understood. We hypothesized that LGG significantly modulates the specific neonatal gut microbial populations changes and the inflammatory response elicited by the enteral introduction of septicemia-producing E. coli. To test this hypothesis, newborn rats were pretreated orally with LGG or placebo prior to infection with the neonatal E. coli septicemia clinical isolate SCB34. Amplicon 16S rRNA gene sequencing was performed on intestinal samples. Intestinal injury and expression of inflammatory mediators and apoptosis were determined.
RESULTS: Alpha diversity of gut microbiota was greater in SCB34-infected pups in comparison to sham-infected pups, these changes were not modified by LGG pretreatment. Beta diversity analyses also showed differences between SCB34-infected vs. uninfected pups. LGG pretreatment before SCB34 infection did not result in significant beta diversity changes compared to placebo. Moreover, individual genera and species abundance analyses by linear discriminant analysis effect size (LEfSe) showed significant changes in Gram-negative, Gram-positive, and anaerobic populations resulting from LGG pretreatment and SCB34 infection. LGG significantly suppressed the expression of inflammatory cytokines but did not attenuate SCB34-induced apoptosis or histologic injury.
CONCLUSIONS: LGG modulates clinically significant microbiota features and inflammation triggered by pathogenic E. coli intestinal infection shortly after birth. This new knowledge can potentially be harnessed to design novel interventions against gut-derived neonatal sepsis.
Journal Title
BMC microbiology [electronic resource]
Volume
24
Issue
1
First Page
452
Last Page
452
MeSH Keywords
Lacticaseibacillus rhamnosus; Animals; Gastrointestinal Microbiome; Probiotics; Escherichia coli; Animals, Newborn; Escherichia coli Infections; Rats; RNA, Ribosomal, 16S; Inflammation; Rats, Sprague-Dawley; Neonatal Sepsis; Disease Models, Animal; Apoptosis
Keywords
Lactobacillus rhamnosus, Escherichia coli, neonatal sepsis; Animals, newborn; Gastrointestinal microbiome; Inflammation mediators; Probiotics
Recommended Citation
Xuan H, Umar S, Zhong C, et al. Lactobacillus rhamnosus modulates murine neonatal gut microbiota and inflammation caused by pathogenic Escherichia coli. BMC Microbiol. 2024;24(1):452. Published 2024 Nov 6. doi:10.1186/s12866-024-03598-6
Comments
Grants and funding
This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Publisher's Link: https://bmcmicrobiol.biomedcentral.com/articles/10.1186/s12866-024-03598-6